Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature-Reference-Cited by-同舟云学术

Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature

Published:2020-11-23 Issue:5 Volume:40 Page:1881-1887
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Rocha Francisco Airton Castro^ORCID,Pinto Ana Carolina Matias Dinelly^ORCID,Lopes Jailson Rodrigues^ORCID,Deodhar Atul^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-020-05519-0.pdf

Reference22 articles.

1. Graudal N, Hubeck-Graudal T, Tarp S, Christensen R, Jürgens G (2014) Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials. PLoS One 9(9):e106408. https://doi.org/10.1371/journal.pone.0106408eCollection 2014

2. Singh S, Fumery M, Singh AG, Singh N, Prokop LJ, Dulai PS, Sandborn WJ, Curtis JR (2020) Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res 72(4):561–576. https://doi.org/10.1002/acr.23875

3. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, Kissling RO, Tamborrini G, Wildi LM, Nissen MJ, Zufferey P, Bernhard J, Weber U, Landewé RBM, van der Heijde D, Ciurea A (2018) Rheumatologists of the Swiss Clinical Quality Management Program. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 77(1):63–69. https://doi.org/10.1136/annrheumdis-2017-211544

4. Haroon N, Inman R, Learch TJ, Weisman MH, Lee M, Rahbar MH, Ward MM, Reveille JD, Gensler LS (2013) The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 65(10):2645–2654. https://doi.org/10.1002/art.38070

5. Maas F, Arends S, Brouwer E, Essers I, van der Veer E, Efde M, van Ooijen PMA, Wolf R, Veeger NJGM, Bootsma H, Wink FR, Spoorenberg A (2017) Reduction in spinal radiographic progression in ankylosing spondylitis patients receiving prolonged treatment with tumor necrosis factor inhibitors. Arthritis Care Res 69(7):1011–1019. https://doi.org/10.1002/acr.23097

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of biologic therapy in patients with ankylosing spondylitis and coxitis: dynamics of clinical and laboratory parameters and structural progression;Modern Rheumatology Journal;2024-02-21

2. The causal relationship between ankylosing spondylitis and the risk of ovarian cancer;Human Immunology;2023-11

3. Effect of Tumor Necrosis Factor Inhibitors on Hip Involvement in Ankylosing Spondylitis: Is Structural Repair Possible?;The Journal of Rheumatology;2023-10-15

4. Drs. Konsta and van der Horst-Bruinsma reply;The Journal of Rheumatology;2023-10-15

5. Consensus on targeted drug therapy for spondyloarthritis;Rheumatology and Immunology Research;2023-06-01